Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation
暂无分享,去创建一个
S. Nomura | T. Kurata | T. Miyara | Yoshitaro Torii | T. Yokoi | K. Kibata | Maiko Niki | Makoto Ogata | A. Nakaya | Y. Katashiba | Y. Takeyasu